Screening of family members of patients with acute brucellosis in an endemic area of Iran
Abstract
Background and Objectives: Brucellosis is a zoonotic disease and it’s still endemic in Iran. There are some reports regarding brucellosis infection in family members sharing same risk factors and remain unrecognized. However, few studies on the importance of family screening are available. We aimed to screen household members of index cases with acute brucellosis for detecting additional unrecognized cases in central province of Iran.
Patients and Methods: 163 family members of 50 index cases were enrolled in the study. Standard Tube Agglutination Test (STA) and 2-mercaptoethanol (2ME) agglutination were checked in all samples. A case with STA titer ≥ 1:80,2-mercaptoethanol (2ME) agglutination ≥ 40 and compatible signs and symptoms was considered positive for brucellosis.
Results: 15 (9.2%) of family members were seropositive for Brucella agglutinin and among them, 8 (53.3%) were asymptomatic and 7 (46.7%) were symptomatic. STA titer ranged from 1:80 to 1:640 in seropositive members. 4 of the 15 seropositive cases who identified by screening came from one index case with 6 family members. All symptomatic seropositive cases treated for Brucella infection and recovered without any complications in 6 months follow up.
Conclusion: On the basis of our data, family members of brucellosis patients are at risk of disease acquisition, and screening of household members provides an effective way for early diagnosis and prompt treatment. However cost benefit of screening should be evaluated to reach definite decision for the implementation of the screening as a nationwide program.
Pappas G, Papadimitriou P, Akritidis N, Christou L, TsianosEV.Thenewglobalmapof human brucellosis.Lancet Infect Dis 2006; 6: 91-99.
Sofian M, Aghakhani A, Velayati AA, Banifazl M, Eslamifar A, Ramezani A. Risk factors for human brucellosis in Iran: a case-control study. Int J Infect Dis 2008; 12: 157-161.
Farahani SH, Shah Mohamadi S, Navidi I , Sofian M. An investigation of the epidemiology of brucellosis in Arak City, Iran, (2001-2010). Arak Medical University Journal 2012; 14: 49-54 [In Persian]
Fosgate GT, Carpenter TE, Chomel BB, Case JT, DeBess EE, Reilly KF. Time-space clustering of human brucellosis, California, 1973-1992. Emerg Infect Dis 2002; 8: 672-678.
Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol 2010;140 :392-398.
Bikas C, Jelastopulu E, Leotsinidis M, Kondakis X. Epidemiology of human brucellosis in a rural area of north-western Peloponnese in Greece. Eur J Epidemiol 2003;18: 267-274.
Aypak C, Altunsoy A, Kutta Çelik A. Epidemiological and clinical aspects of human brucellosis in eastern anatolia. J Nippon Med Sch 2012; 79: 343-348.
Khan MY, Mah MW, Memish Z. Brucellosis in pregnant women. Clin Infect Dis 2001; 32: 1172-1177.
Aleissa YA. Probable breast milk borne brucellosis in a young infant. Ann Trop Pediatr 1990; 10: 305-307.
Aleissa YA, Almofada SM. Congenital brucellosis.Pediatr Infect Dis J 1992; 11: 667-671.
Gotuzzo E, Carrillo C, Seas C, Guerra J, Maguiña C.Epidemiological and clinical features of brucellosis in 39 family groups. Enferm Infec Microbiol Clin 1989;7: 519-524.
Abramson O, Rosenvasser Z, Block C, Dagan R.Detection and treatment of brucellosis by screening a population at risk. Pediatr Infect Dis J 1991; 10: 434-438.
AlmuneefMA,MemishZA,BalkhyHH,AlotaibiB, Algoda S, Abbas M, et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect 2004; 132: 533-540.
Alsubaie S, Almuneef M, Alshaalan M, Balkhy H, Albanyan E, Alola S, et al. Acute brucellosis in Saudi families: relationship between brucella serology and cli nical symptoms. Int J Infect Dis. 2005; 9: 218-224.
Almuneef M, Memish Z. Persistence of brucella antibodies after successful treatment of acute brucellosis in an area of endemicity. J Clin Microbiol 2002; 40: 2313.
Hasanjani MR, Mohrez M, Smailnejad SM, Soleimani MJ, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, northern Iran. Epidemiol Infect 2004; 132: 1109-1114.
Tabak F, Hakko E, Mete B, Ozaras R, Mert A, Ozturk R.Is family screening necessary in brucellosis? Infection 2008; 36: 575-577.
Mendoza-Núñez M, Mulder M, Franco MP, Maas KS, Castañeda ML, Bonifacio N, et al; Brucellosis Working Group in Callao. Brucellosis in household members of Brucella patients residing in a large urban setting in Peru. Am J Trop Med Hyg. 2008; 78: 595-8.
Sharifi-Mood B, Metanat M, Alavi-Naini R. Screening of the family members of patients with acute brucellosi s in Southeast Iran. Indian J Med Microbiol. 2007; 25:176-177.
Karabay O, Serin E, Tamer A, Go¨kdog˘an F, Alpteker H, Ozcan A, et al. Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiologic study. Turk J Gastroenterol 2004; 15: 11-3.
Husseini AS, Ramlawi AM. Brucellosis in the West Bank, Palestine. Saudi Med J 2004; 25: 1640-3.
Rasouli M, Kiany S. Association of interferon- gamma and interleukin-4 gene polymorphisms with susceptibility to brucellosis in Iranian patients. Cytokine 2007; 38: 49-53.
Budak F, Göral G, Heper Y, Yilmaz E, Aymak F, Bas¸türk B, et al. IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in brucellosis. Cytokine 2007; 38: 32-36.
Gur A, Geyik MF, Dikici B, Nas K, Cevik R, Sarac J, et al. Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey Yonsei Med J. 2003; 44: 33-44.
El Miedany YM, ElGaafary M, Baddour M, Ahmed I.Human Brucellosis: do we need to revise our therapeutic policy? J Rheumatol 2003; 30: 2666-72.
Files | ||
Issue | Vol 5 No 3 (2013) | |
Section | Articles | |
Keywords | ||
Acute Brucellosis Family member Index cases Screening |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |